SCHEMBL1645396

SCHEMBL1645396

CC(=O)CC(=O)CCc1ccc(O)cc1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.55
F13A1 P00488 1/20 0.55
F2RL1 P55085 1/20 0.53
HDAC2 Q92769 1/20 0.51
HDAC8 Q9BY41 1/20 0.51
TRPV1 Q8NER1 2/20 0.49
ESR1 P03372 2/20 0.48
ESR2 Q92731 1/20 0.48
BACE1 P56817 3/20 0.48
ALDH1A1 P00352 2/20 0.47
CYP19A1 P11511 2/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
SLC16A3 O15427 1/20 0.47
LMNA P02545 1/20 0.47
TTR P02766 1/20 0.47
TP53 P04637 1/20 0.47
CYP1A2 P05177 1/20 0.47
POLB P06746 1/20 0.47
CYP3A4 P08684 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Letestuianin C SCHEMBL4410123 0.88 F2RL1 (0.60) KDM4EF13A1F2RL1HDAC2HDAC8
SCHEMBL12354595 0.85 F2RL1 (0.53) KDM4EF13A1F2RL1ALDH1A1POLB
SCHEMBL4021741 0.85 F2RL1 (0.53) KDM4EF2RL1HDAC2HDAC8ALDH1A1
SCHEMBL13577768 0.85 TDP1 (0.59) F2RL1ALDH1A1KMT2ASLC5A1SLC5A2
Raspberryketone SCHEMBL43308 0.84 ALDH1A1 (0.65) KDM4EF13A1HDAC2HDAC8ESR1
SCHEMBL8108885 0.83 ESR1 (0.62) KDM4EF13A1F2RL1HDAC2HDAC8
SCHEMBL4409944 0.83 F2RL1 (0.56) KDM4EF13A1F2RL1HDAC2HDAC8
SCHEMBL12787142 0.83 F2RL1 (0.51) KDM4EF2RL1ALDH1A1POLBRECQL
SCHEMBL2206622 0.82 ALDH1A1 (0.70) KDM4EF2RL1HDAC2HDAC8ALDH1A1
SCHEMBL2862583 0.82 MMP12 (0.68) KDM4EF13A1F2RL1HDAC2HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9738605-B2 Hybrid compounds of curcumin and melatonin as neuroprotectants for neurodegenerative disorders VIRGINIA COMMONWEALTH UNIVERSITY (US) 2017-08-22 US disclosed
US-8962674-B2 Curcumin derivative TOKYO INSTITUTE OF TECHNOLOGY (JP) 2015-02-24 US disclosed
US-8552220-B2 Therapeutic agent for Alzheimer's disease TOKYO INSTITUTE OF TECHNOLOGY (JP) 2013-10-08 US disclosed
US-20110082295-A1 NOVEL CURCUMIN DERIVATIVE TOKYO INSTITUTE OF TECHNOLOGY (JP) 2011-04-07 US disclosed
EP-2305629-A1 THERAPEUTIC AGENT FOR ALZHEIMER'S DISEASE Tokyo Institute of Technology (JP) 2011-04-06 EP disclosed
WO-2010093706-A2 CHEMICALLY PROGRAMMED VACCINATION THE SCRIPPS RESEARCH INSTITUTE (US) 2010-08-19 WO disclosed
US-7763365-B2 Light emitting material and organic light-emitting device SHOWA DENKO K.K. (JP) 2010-07-27 US disclosed
US-7763365-B2 Light emitting material and organic light-emitting device SHOWA DENKO K.K. (JP) 2010-07-27 US disclosed
US-7763365-B2 Light emitting material and organic light-emitting device SHOWA DENKO K.K. (JP) 2010-07-27 US disclosed
US-7736757-B2 Light emitting material and organic light-emitting device SHOWA DENKO K.K. (JP) 2010-06-15 US disclosed
US-20080290792-A1 LIGHT EMITTING MATERIAL AND ORGANIC LIGHT-EMITTING DEVICE SHOWA DENKO K.K. (JP) 2008-11-27 US disclosed
US-7396598-B2 Light emitting material and organic light-emitting device SHOWA DENKO K.K. (JP) 2008-07-08 US disclosed
US-7396598-B2 Light emitting material and organic light-emitting device SHOWA DENKO K.K. (JP) 2008-07-08 US disclosed
US-7396598-B2 Light emitting material and organic light-emitting device SHOWA DENKO K.K. (JP) 2008-07-08 US disclosed
US-20080152947-A1 LIGHT EMITTING MATERIAL AND ORGANIC LIGHT-EMITTING DEVICE SHOWA DENKO K.K. (JP) 2008-06-26 US disclosed
US-20080152947-A1 LIGHT EMITTING MATERIAL AND ORGANIC LIGHT-EMITTING DEVICE SHOWA DENKO K.K. (JP) 2008-06-26 US disclosed
US-20080152947-A1 LIGHT EMITTING MATERIAL AND ORGANIC LIGHT-EMITTING DEVICE SHOWA DENKO K.K. (JP) 2008-06-26 US disclosed
US-20040247934-A1 Light emitting material and organic light-emitting device SAMSUNG ELECTRONICS CO., LTD (KR) 2004-12-09 US disclosed
EP-1407501-A2 LIGHT EMITTING MATERIAL AND ORGANIC LIGHT-EMITTING DEVICE Showa Denko K.K. (JP) 2004-04-14 EP disclosed
WO-2003001616-A2 LIGHT EMITTING MATERIAL AND ORGANIC LIGHT-EMITTING DEVICE SHOWA DENKO K.K. (JP) 2003-01-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110082295-A1 NOVEL CURCUMIN DERIVATIVE BACE1, APP, BACE2 KDM4E 1786/4885F13A1 4269/4885F2RL1 1145/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.